
Venkataraman Balasubramanian
Examiner (ID: 8143, Phone: (571)272-0662 , Office: P/1624 )
| Most Active Art Unit | 1624 |
| Art Unit(s) | 1624, 1611 |
| Total Applications | 2999 |
| Issued Applications | 2024 |
| Pending Applications | 254 |
| Abandoned Applications | 724 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 13328365
[patent_doc_number] => 20180215720
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-02
[patent_title] => PYRIMIDINES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/879826
[patent_app_country] => US
[patent_app_date] => 2018-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16742
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15879826
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/879826 | Pyrimidines and uses thereof | Jan 24, 2018 | Issued |
Array
(
[id] => 15209653
[patent_doc_number] => 20190367513
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-05
[patent_title] => BICYCLIC BIS-HETEROARYL DERIVATIVES AS MODULATORS OF PROTEIN AGGREGATION
[patent_app_type] => utility
[patent_app_number] => 16/480254
[patent_app_country] => US
[patent_app_date] => 2018-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17127
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16480254
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/480254 | Bicyclic bis-heteroaryl derivatives as modulators of protein aggregation | Jan 22, 2018 | Issued |
Array
(
[id] => 16635240
[patent_doc_number] => 10913735
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-02-09
[patent_title] => Bis-heteroaryl derivatives as modulators of protein aggregation
[patent_app_type] => utility
[patent_app_number] => 16/480252
[patent_app_country] => US
[patent_app_date] => 2018-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14334
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 184
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16480252
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/480252 | Bis-heteroaryl derivatives as modulators of protein aggregation | Jan 22, 2018 | Issued |
Array
(
[id] => 15293359
[patent_doc_number] => 20190389815
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-26
[patent_title] => Benzylaminopyrazinylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/479226
[patent_app_country] => US
[patent_app_date] => 2018-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14329
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16479226
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/479226 | Benzylaminopyrazinylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof | Jan 21, 2018 | Issued |
Array
(
[id] => 15147667
[patent_doc_number] => 20190352311
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-21
[patent_title] => THIENOPYRIMIDINE DERIVATIVE AND USE THEREOF IN MEDICINE
[patent_app_type] => utility
[patent_app_number] => 16/476290
[patent_app_country] => US
[patent_app_date] => 2018-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32522
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16476290
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/476290 | Thienopyrimidine derivative and use thereof in medicine | Jan 21, 2018 | Issued |
Array
(
[id] => 15086181
[patent_doc_number] => 20190337901
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-07
[patent_title] => SUBSTITUTED 3-DIALKYLAMINOMETHYL-PIPERIDIN-4-YL-BENZAMIDES AND METHODS OF MAKING AND USING SAME
[patent_app_type] => utility
[patent_app_number] => 16/477817
[patent_app_country] => US
[patent_app_date] => 2018-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23645
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 218
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16477817
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/477817 | Substituted 3-dialkylaminomethyl-piperidin-4-yl-benzamides and methods of making and using same | Jan 16, 2018 | Issued |
Array
(
[id] => 12728698
[patent_doc_number] => 20180134733
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-17
[patent_title] => HIGHLY DISPERSIBLE ANTIMICROBIAL AND ADHESION AGENTS
[patent_app_type] => utility
[patent_app_number] => 15/872516
[patent_app_country] => US
[patent_app_date] => 2018-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1827
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15872516
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/872516 | HIGHLY DISPERSIBLE ANTIMICROBIAL AND ADHESION AGENTS | Jan 15, 2018 | Abandoned |
Array
(
[id] => 13371847
[patent_doc_number] => 20180237464
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-23
[patent_title] => PHOTOACTIVE ENERGETIC MATERIALS
[patent_app_type] => utility
[patent_app_number] => 15/868562
[patent_app_country] => US
[patent_app_date] => 2018-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17722
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15868562
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/868562 | Photoactive energetic materials | Jan 10, 2018 | Issued |
Array
(
[id] => 13289169
[patent_doc_number] => 10155760
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-12-18
[patent_title] => Biaryl kinase inhibitors
[patent_app_type] => utility
[patent_app_number] => 15/865848
[patent_app_country] => US
[patent_app_date] => 2018-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 52594
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15865848
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/865848 | Biaryl kinase inhibitors | Jan 8, 2018 | Issued |
Array
(
[id] => 12746308
[patent_doc_number] => 20180140603
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-24
[patent_title] => POLYMORPHS OF ARRY-380, A SELECTIVE HER2 INHIBITOR AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
[patent_app_type] => utility
[patent_app_number] => 15/861444
[patent_app_country] => US
[patent_app_date] => 2018-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23249
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15861444
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/861444 | Polymorphs of ARRY-380, a selective HER2 inhibitor and pharmaceutical compositions containing them | Jan 2, 2018 | Issued |
Array
(
[id] => 12884800
[patent_doc_number] => 20180186775
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-05
[patent_title] => QUINOXALINE DERIVATIVES USEFUL AS FGFR KINASE MODULATORS
[patent_app_type] => utility
[patent_app_number] => 15/856998
[patent_app_country] => US
[patent_app_date] => 2017-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23677
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15856998
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/856998 | Quinoxaline derivatives useful as FGFR kinase modulators | Dec 27, 2017 | Issued |
Array
(
[id] => 16169442
[patent_doc_number] => 10710990
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-07-14
[patent_title] => Method for producing glyceric acid ester
[patent_app_type] => utility
[patent_app_number] => 16/473177
[patent_app_country] => US
[patent_app_date] => 2017-12-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 15093
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 174
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16473177
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/473177 | Method for producing glyceric acid ester | Dec 25, 2017 | Issued |
Array
(
[id] => 16169442
[patent_doc_number] => 10710990
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-07-14
[patent_title] => Method for producing glyceric acid ester
[patent_app_type] => utility
[patent_app_number] => 16/473177
[patent_app_country] => US
[patent_app_date] => 2017-12-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 15093
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 174
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16473177
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/473177 | Method for producing glyceric acid ester | Dec 25, 2017 | Issued |
Array
(
[id] => 16169442
[patent_doc_number] => 10710990
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-07-14
[patent_title] => Method for producing glyceric acid ester
[patent_app_type] => utility
[patent_app_number] => 16/473177
[patent_app_country] => US
[patent_app_date] => 2017-12-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 15093
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 174
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16473177
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/473177 | Method for producing glyceric acid ester | Dec 25, 2017 | Issued |
Array
(
[id] => 16169442
[patent_doc_number] => 10710990
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-07-14
[patent_title] => Method for producing glyceric acid ester
[patent_app_type] => utility
[patent_app_number] => 16/473177
[patent_app_country] => US
[patent_app_date] => 2017-12-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 15093
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 174
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16473177
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/473177 | Method for producing glyceric acid ester | Dec 25, 2017 | Issued |
Array
(
[id] => 15308861
[patent_doc_number] => 10519121
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-12-31
[patent_title] => Process and novel polymorphic form of vortioxetine and its pharmaceutically acceptable salts
[patent_app_type] => utility
[patent_app_number] => 15/854458
[patent_app_country] => US
[patent_app_date] => 2017-12-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4923
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15854458
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/854458 | Process and novel polymorphic form of vortioxetine and its pharmaceutically acceptable salts | Dec 25, 2017 | Issued |
Array
(
[id] => 15147655
[patent_doc_number] => 20190352305
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-21
[patent_title] => DIARYL PURINE DERIVATIVES WITH IMPROVED BIOAVAILABILITY
[patent_app_type] => utility
[patent_app_number] => 16/472155
[patent_app_country] => US
[patent_app_date] => 2017-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22568
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16472155
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/472155 | Diaryl purine derivatives with improved bioavailability | Dec 19, 2017 | Issued |
Array
(
[id] => 15117027
[patent_doc_number] => 20190345146
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-14
[patent_title] => NITROGEN CONTAINING BICYCLIC DERIVATIVES FOR TREATING PAIN AND PAIN RELATED CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 16/470581
[patent_app_country] => US
[patent_app_date] => 2017-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12001
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16470581
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/470581 | NITROGEN CONTAINING BICYCLIC DERIVATIVES FOR TREATING PAIN AND PAIN RELATED CONDITIONS | Dec 19, 2017 | Abandoned |
Array
(
[id] => 15586313
[patent_doc_number] => 20200069691
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-05
[patent_title] => HETEROCYCLIC COMPOUNDS AS HIV PROTEASE INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/461899
[patent_app_country] => US
[patent_app_date] => 2017-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20235
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 304
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16461899
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/461899 | HETEROCYCLIC COMPOUNDS AS HIV PROTEASE INHIBITORS | Dec 18, 2017 | Abandoned |
Array
(
[id] => 16072203
[patent_doc_number] => 20200190088
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-18
[patent_title] => PROCESS FOR PREPARING TEMOZOLOMIDE AND AN INTERMEDIARY
[patent_app_type] => utility
[patent_app_number] => 16/471524
[patent_app_country] => US
[patent_app_date] => 2017-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4025
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16471524
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/471524 | Process for preparing temozolomide and an intermediary | Dec 18, 2017 | Issued |